Soleno Therapeutics, Inc. - Common Stock (SLNO)
50.27
-0.10 (-0.20%)
Soleno Therapeutics Inc is a biopharmaceutical company focused on developing innovative therapies for rare diseases, particularly those associated with genetic and metabolic disorders
The company is committed to addressing significant unmet medical needs by advancing its proprietary treatment candidates through clinical trials. With an emphasis on leveraging cutting-edge science and research, Soleno aims to bring novel solutions to patients suffering from conditions like Prader-Willi syndrome, thereby enhancing their quality of life and overall health outcomes.
Previous Close | 50.37 |
---|---|
Open | 50.43 |
Bid | 50.21 |
Ask | 50.28 |
Day's Range | 49.54 - 51.27 |
52 Week Range | 36.61 - 60.92 |
Volume | 166,743 |
Market Cap | 410.64M |
PE Ratio (TTM) | -18.62 |
EPS (TTM) | -2.7 |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 442,788 |
News & Press Releases
![](https://g.foolcdn.com/editorial/images/793485/person-in-a-lab-gazing-into-a-microscope.jpg)
The company's Prader-Willi treatment inched closer to FDA approval.
Via The Motley Fool · October 8, 2024
![](https://cdn.benzinga.com/files/images/story/2024/10/08/movers-image_12.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · October 8, 2024
![](https://cdn.benzinga.com/files/images/story/2024/08/27/movers-image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · August 27, 2024
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
SLNO stock results show that Soleno Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
Via InvestorPlace · August 7, 2024
![](https://cdn.benzinga.com/files/images/story/2024/05/29/StockMarket-Up-Shutterstock.jpeg?width=1200&height=800&fit=crop)
NVIDIA Corp. (NASDAQNVDA) has been the standout tech stock of the past year, leading the Nasdaq 100 index in the performance ranking.
Via Benzinga · May 29, 2024
![](https://g.foolcdn.com/editorial/images/774875/fda-blocks-in-hand.jpg)
The clinical-stage biotech company received great news from the FDA.
Via The Motley Fool · April 29, 2024
Soleno Therapeutics Inc. (NASDAQ: SLNO) is a Stock Spotlight on 2/22
Soleno Therapeutics, Inc. (NASDAQSLNO) is the focus of IBN’s latest stock spotlight. The company’s shares have moved -1.14% on the day to $48.05.
Via Investor Brand Network · February 22, 2024
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
SLNO stock results show that Soleno Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.
Via InvestorPlace · May 9, 2024
![](https://cdn.benzinga.com/files/images/story/2024/04/29/wall-street-chart-shutter3.jpeg?width=1200&height=800&fit=crop)
U.S. stocks kicked off the week on a positive note, with all major averages edging higher in anticipation of significant events including earnings reports from tech giants like Amazon.com Inc. (NASDAQAMZN) on Tuesday and Apple Inc.
Via Benzinga · April 29, 2024
![](/next-assets/images/schema-image-default.png)
Via Benzinga · April 29, 2024
![](https://cdn.benzinga.com/files/images/story/2024/04/29/Tesla-logo_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · April 29, 2024
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
SLNO stock results show that Soleno Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023.
Via InvestorPlace · March 6, 2024
Soleno Therapeutics Inc. (NASDAQ: SLNO) is a Stock Spotlight on 2/20
Soleno Therapeutics, Inc. (NASDAQSLNO) is the focus of IBN’s latest stock spotlight. The company’s shares have moved 2.83% on the day to $48.66.
Via Investor Brand Network · February 20, 2024
Soleno Therapeutics Inc. (NASDAQ: SLNO) Climbs to New 52-Week High
Shares of Soleno Therapeutics, Inc. (NASDAQSLNO) traded at a new 52-week high today and are currently trading at $23.03. So far today, approximately 140.58k shares have been exchanged, as compared to an average 30-day volume of 383.77k shares.
Via Investor Brand Network · January 9, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · January 29, 2024
![](https://cdn.benzinga.com/files/images/story/2023/Bajaj-Electricals-shares-are-surging-tod_0.jpeg?width=1200&height=800&fit=crop)
Baron Fifth Avenue Growth Fund gained nearly 60% over the year, while the Fidelity Blue Chip Growth ETF climbed 59%.
Via Benzinga · December 28, 2023
![](https://cdn.benzinga.com/files/images/story/2023/Stock-Market-Graph-Trading-Analysis-Inve_18.jpeg?width=1200&height=800&fit=crop)
The two companies outperformed the 'Magnificent Seven' group of stocks, which includes tech giants such as Nvidia, Apple, and Microsoft.
Via Benzinga · December 28, 2023
![](https://g.foolcdn.com/editorial/images/759146/person-in-a-lab-looking-through-a-microscope.jpg)
The latest pundit take on the stock provided a good reason for bulls to snap it up.
Via The Motley Fool · December 21, 2023
![](https://investorplace.com/wp-content/uploads/2019/07/cash1600c.jpg)
These three stocks to take profits on rallied more than 200% this year. Those gains are exceedingly unlikely to repeat in 2024.
Via InvestorPlace · December 14, 2023
![](https://investorplace.com/wp-content/uploads/2023/07/businessman-mountain-growth-stocks-flag-peak-1600.jpg)
If you want to find 2023's top-performing stock, check out these companies that returned 500% or more since January
Via InvestorPlace · December 14, 2023
![](https://investorplace.com/wp-content/uploads/2020/03/bonus-pay-money.jpg)
Could any or all of these seven stocks up 1000% this year go on another hot run during 2024? Let's find out.
Via InvestorPlace · December 12, 2023
![](https://investorplace.com/wp-content/uploads/2023/12/jackpot1600.jpg)
These stocks to buy have the potential to take your portfolio to the next level thanks to the cutting-edge technology they represent.
Via InvestorPlace · December 4, 2023
![](https://investorplace.com/wp-content/uploads/2021/03/gambling-stocks-poker-1600.jpg)
When investors land on a "jackpot" stock, gains can offset even the steepest losses. Here are the top stocks to buy if you're feeling lucky.
Via InvestorPlace · November 27, 2023